SCHEMBL7038457

SCHEMBL7038457

COc1ccc(C(N)C(=O)N2CCCCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.55
MMP3 P08254 1/20 0.55
MMP13 P45452 1/20 0.55
ADAM17 P78536 1/20 0.55
HPGD P15428 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
ALOX15 P16050 1/20 0.54
HTT P42858 1/20 0.54
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
ALDH1A1 P00352 5/20 0.51
ALOX5 P09917 1/20 0.51
MAPT P10636 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 2/20 0.49
TP53 P04637 1/20 0.47
POLB P06746 2/20 0.47
DPP7 Q9UHL4 4/20 0.47
DPP4 P27487 3/20 0.46
PREP P48147 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7038451 1.00 MMP1 (0.55) MMP1MMP3MMP13ADAM17HPGD
SCHEMBL365418 0.82 HPGD (0.51) MMP1MMP3MMP13ADAM17HPGD
SCHEMBL13267430 0.82 HPGD (0.51) MMP1MMP3MMP13ADAM17HPGD
SCHEMBL10179952 0.82 HPGD (0.51) MMP1MMP3MMP13ADAM17HPGD
SCHEMBL12324842 0.82 HPGD (0.51) MMP1MMP3MMP13ADAM17HPGD
SCHEMBL371088 0.82 HPGD (0.51) MMP1MMP3MMP13ADAM17HPGD
Hydrochloric Acid SCHEMBL295178 0.81 HPGD (0.50) MMP1MMP3MMP13ADAM17HPGD
SCHEMBL13632802 0.79 HPGD (0.53) HPGDSMN1; SMN2HTTKMT2AMEN1
SCHEMBL4984200 0.79 HPGD (0.53) HPGDSMN1; SMN2HTTKMT2AMEN1
SCHEMBL4597495 0.78 HDAC6 (0.44) MMP1MMP3MMP13ADAM17HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed